NCT04699006View on ClinicalTrials.gov

Efficacy and Adverse Effects of Olaparib in Ovarian Cancer.

Enrolling by invitationOBSERVATIONAL

Enrollment

245

Participants

Timeline

Start Date

January 21, 2021

Primary Completion Date

January 1, 2024

Study Completion Date

January 1, 2026

Conditions

Ovarian Cancer

Trial Locations (1)

710061

The First Affliated Hospital of Xi'an Jiaotong University, Xi'an

All Listed Sponsors

lead

First Affiliated Hospital Xi'an Jiaotong University

OTHER